Method Validation [Bioanalytics]

posted by Loky do – Egypt, 2025-03-13 12:19 (448 d 01:13 ago) – Posting: # 24386
Views: 5,108

Dears
Appreciate your advice
What are the potential implications of mistakenly designing the QC high at 70% of the upper limit and analyzing study samples based on this? Would re-validation and reanalysis of all samples be required, or could this deviation be accepted by regulatory authorities?

Thanks in Advance
LD

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
468 visitors (0 registered, 468 guests [including 16 identified bots]).
Forum time: 14:33 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5